Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of PDGFR Kinase Inhibitor in Biomarker-Enriched Recurrent Malignant Gliomas

NCT01140568 is registered in ClinicalTrials.gov with David Piccioni, M.D., Ph.D as lead sponsor.

NCT NCT01140568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01140568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of PDGFR Kinase Inhibitor in Biomarker-Enriched Recurrent Malignant Gliomas
Lead sponsor
David Piccioni, M.D., Ph.D
Phase
Phase 2
Overall status
Completed
Start date
April 21, 2010
Completion date
January 31, 2019
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma